ProQR Therapeutics (PRQR) Current Assets (2013 - 2025)

ProQR Therapeutics' Current Assets history runs 13 years deep, the most recent figure standing at $116.6 million for Q4 2025.

• In Q4 2025, Current Assets fell 29.1% year-over-year to $116.6 million; the TTM figure through Dec 2025 stood at $116.6 million (down 29.1% YoY), while the FY2025 annual figure was $116.6 million, down 29.1% from the prior year.
• Current Assets came in at $116.6 million for Q4 2025 at ProQR Therapeutics, down from $164.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $219.1 million in Q4 2021 to a low of $87893.6 in Q1 2021.
• A 5-year average of $147.9 million and a median of $154.8 million in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets plunged 99.92% in 2021 and jumped 220132.99% in 2022, its largest moves.
• ProQR Therapeutics' Current Assets stood at $219.1 million in 2021, then declined by 28.06% to $157.6 million in 2022, then retreated by 17.4% to $130.2 million in 2023, then grew by 26.29% to $164.4 million in 2024, then fell by 29.1% to $116.6 million in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $116.6 million, $164.4 million, and $130.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison